Rare diseases
Investigational molecules
Locations
Back to Portugal263 clinical trials in Coimbra, Portugal across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
PortugalLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PortugalA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
PortugalA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
PortugalStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
PortugalA study of navenibart for long-term safety in patients with hereditary angioedema
PortugalStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PortugalStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
PortugalStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
PortugalStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
PortugalStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
PortugalStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials investigating treatments for polypoidal choroidal vasculopathy and thyroid eye disease, focusing on improving visual outcomes and reducing eye-related complications.
Advanced therapeutic approaches using intravitreal injections and targeted medications.
Groundbreaking research addressing various skin conditions including hidradenitis suppurativa, pyoderma gangrenosum, and neurodermatitis.
Novel therapeutic approaches targeting specific inflammatory pathways.
Comprehensive studies exploring treatments for cardiovascular disease and pulmonary arterial hypertension, with focus on preventing major adverse cardiac events.
Innovative therapies targeting specific cardiovascular risk factors.
Advanced research in ischemic stroke, epilepsy, and migraine treatments, exploring both acute interventions and preventive therapies.
Cutting-edge therapeutic approaches for neurological disorders.
Studies focusing on breast cancer, non-small cell lung cancer, and leiomyosarcoma, developing targeted therapies for various cancer types.
Innovative approaches in cancer treatment and management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
